Compounds > 3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione
Page last updated: 2024-09-04

3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione and Disease Exacerbation

3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Baldwin, T; Beck, D; Bourgeat, P; Faux, NG; Fedyashov, V; Fripp, J; Goudey, B; Masters, CL; Saint-Jalmes, M1

Other Studies

1 other study(ies) available for 3-(3,5-dichlorophenyl)-1-methyl-2,5-pyrrolidinedione and Disease Exacerbation

ArticleYear
Disease progression modelling of Alzheimer's disease using probabilistic principal components analysis.
    NeuroImage, 2023, Volume: 278

    Topics: Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Humans; Magnetic Resonance Imaging; Neuroimaging

2023